I beg to differ...a partnership, not a buyout is just what the doctor ordered here..First, if you go from an R and D company, which we are today, to a pharma company after first approval, and you decide to go it alone, the cost is huge. I worked for a pharma and later supported a Biotech company who went from R and D to a drug company on their own. they went from 200 employees to over 1200 in 9 months and it almost crushed them..you have to have a strong, large salesforce if we are going to play, for example, in the cancer space. No drug leaps off the page on its own for doctors. we love our drug but doctors are getting pitches from 10 other drug companies at the same time. besides a need of a helluva lot of sales people plus a large marketing budget to compete. then you have to build the back office..Accounting, IT, etc, etc..The cost is huge... This management team knows that and none have built a company of the magnitude that needs to be built without a partnership.
the partnership even for one key application would be 10's if not hundreds of millions in license fees plus a percentage of the sales. plus you have 1,000 reps ready to hit the ground selling your product after training.. its a no brainer IMO